Investigating the 3D structures of proteins from infectious diseases
Official title: Centers for Research on Structural Biology of Infectious Diseases
Funded at Northwestern University at Chicago · NIH-11160416 · Data updated 2026-11-12
This study is looking at the shapes of certain proteins linked to infectious diseases to help scientists understand how these germs work, which could lead to better treatments or vaccines for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | September 1, 2022 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $360,000 |
| NIH project number | 75N93022C00035-P00010-9999-4 |
| Project ID | NIH-11160416 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals affected by or at risk for emerging infectious diseases.
✕Less likely to help
Patients with non-infectious diseases or those not affected by the targeted pathogens may not receive any benefit from this research.
What this research studies
This research focuses on using advanced structural biology techniques to determine the three-dimensional atomic structures of specific proteins associated with infectious diseases. By understanding these structures, researchers aim to uncover the molecular functions of these proteins, which could lead to new insights into how these pathogens operate. The research targets proteins from organisms on the NIAID priority list, including those responsible for emerging and re-emerging infectious diseases. Patients may benefit from this research as it could inform the development of new treatments or vaccines.
Why it matters
Potential benefit: If successful, this research could lead to the development of new therapies or vaccines for infectious diseases.
How similar studies have gone: Other research has shown success in utilizing structural biology to inform drug development and vaccine design, indicating a promising approach.
Where this research is happening
-
Northwestern University at Chicago
Chicago, United States Active
Researchers
- Principal investigator: Satchell, Karla — Northwestern University at Chicago
- Study coordinator: Satchell, Karla
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.